Accession Therapeutics

Developer of therapeutics for cancer treatment

placeAbingdon, England, United Kingdom calendar_todayFounded 2020 groups4 employees language accessiontherapeutics.com

Registered entities

Innovation

5 patent families; filing pace accelerating.

YearFilings
20232
20242
20251

Social engagement

Social engagement: 4.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include IGlobe Partners, Primavera, Birk Venture.

Investor typeCountShare
Venture capital217%
Private equity217%
Other / undisclosed867%

Recent activity

2 Jul 2026
Event
World Bispecific Summit Europe
11 Jun 2026
Event
Stachel Smith Bewick
29 Apr 2026
Event
26th BioEquity Europe and PEGSummit
Coming soon